According to Fortune Business Insights, the global Stents Market size was valued at USD 15.44 billion in 2025. The market is projected to grow from USD 16.02 billion in 2026 to USD 21.54 billion by 2034, exhibiting a CAGR of 3.77% during the forecast period (2026–2034). Increasing cardiovascular disease prevalence, growing demand for minimally invasive procedures, and advancements in drug-eluting and bioresorbable stents are contributing to steady market expansion.
Market Overview
The global Stents Market is experiencing consistent growth due to the increasing adoption of interventional medical procedures. Hospitals, specialty clinics, and ambulatory surgery centers are major end users of stent technologies.
Coronary stents represent the largest product type, accounting for approximately 45% of the market in 2025. North America dominates the global industry with a 38% revenue share, supported by advanced healthcare infrastructure and widespread adoption of cardiovascular interventions.
Manufacturers are investing in research and development to introduce innovative stent designs that improve flexibility, biocompatibility, and long-term clinical performance.
For detailed market insights: https://www.fortunebusinessinsights.com/industry-reports/stents-market-100672
Market Trends
Several emerging trends are transforming the Stents Market landscape.
Increasing Adoption of Drug-Eluting Stents: Advanced drug-eluting technologies are gaining popularity because they help minimize restenosis and improve long-term vessel patency.
Growing Interest in Bioresorbable Stents: Bioresorbable vascular scaffolds provide temporary structural support and gradually dissolve after healing, potentially reducing complications associated with permanent implants.
Development of Bioengineered Stents: Manufacturers are developing specialized surface coatings that encourage endothelial healing and reduce inflammatory responses.
Advancements in Imaging-Guided Procedures: Modern imaging technologies are improving stent placement accuracy, particularly in complex vascular anatomies.
These developments are encouraging healthcare providers to adopt next-generation stent technologies.
Market Drivers
Rising Prevalence of Cardiovascular Diseases
The increasing incidence of coronary artery disease, peripheral vascular disorders, diabetes, and hypertension is a major driver of market growth. Aging populations and sedentary lifestyles are contributing to higher demand for cardiovascular interventions.
Growing Preference for Minimally Invasive Procedures
Stent-based treatments are increasingly preferred over traditional open surgical procedures in suitable cases because they can offer shorter recovery periods and reduced hospitalization requirements.
Technological Advancements
Innovations in drug-eluting coatings, biodegradable materials, and ultra-thin stent structures are improving device performance and expanding clinical applications.
Expansion of Healthcare Infrastructure
Increasing investments in hospitals, catheterization laboratories, and specialized cardiovascular treatment centers are supporting market development, particularly in emerging economies.
However, high procedural costs, strict regulatory requirements, and risks of thrombosis, restenosis, or device migration may limit adoption.
Market Segmentation
The Stents Market is segmented by type, product, material, design, and end user.
By Type
Coronary Stents: Dominated with approximately 45% market share in 2025, driven by widespread coronary artery disease.
Vascular Stents: Accounted for approximately 30%, supported by increasing peripheral artery disease treatments.
Ureteral Stents: Represented approximately 15%, primarily used to manage urinary obstructions.
Esophageal Stents: Held approximately 10%, supporting gastrointestinal and oncology procedures.
By Product
Dual therapy stents and bioengineered stents each represented approximately 35% of advanced stent applications, while bioresorbable vascular scaffolds accounted for approximately 30%.
The report also covers drug-eluting stents and bare-metal stents.
By Material
The market includes non-degradable materials such as stainless steel and degradable materials including magnesium, poly-L-lactic acid, and polycaprolactone.
By Design
Major designs include coil, helical spiral, woven, individual-ring, and sequential-ring structures.
By End User
Hospitals remain important end users, followed by specialty clinics, ambulatory surgery centers, and other healthcare facilities.
Key Players in the Stents Market
Major companies operating in the global Stents Market include:
Medtronic
Abbott
Boston Scientific Corporation
BD
Cardinal Health
Terumo Corporation
Elixir Medical Corporation
Biosensors International Group, Ltd.
Meril Life Sciences Pvt. Ltd.
BIOTRONIK
These companies focus on technological innovation, clinical research, product development, and geographical expansion to strengthen their competitive positions.
Regional Analysis
North America
North America dominated the global Stents Market with approximately 38% market share in 2025. Advanced healthcare infrastructure, favorable reimbursement frameworks, and high cardiovascular intervention volumes support regional leadership.
The United States is a major contributor due to its established catheterization laboratories and strong adoption of innovative medical devices.
Europe
Europe accounted for approximately 27% of the global market. Germany and the United Kingdom are important contributors, supported by established healthcare systems, experienced specialists, and consistent demand for coronary interventions.
Asia Pacific
Asia Pacific represented approximately 25% of the global market. Expanding healthcare infrastructure, increasing cardiovascular disease prevalence, and growing access to minimally invasive procedures are supporting regional expansion.
China and India offer opportunities through healthcare modernization, while Japan emphasizes advanced, high-quality stent technologies.
Rest of the World
Other regions collectively represented approximately 10% of the global market. Increasing healthcare investment, improved medical infrastructure, and growing cardiovascular treatment demand are supporting gradual market development.
Competitive Landscape
The global Stents Market is characterized by competition among established medical device manufacturers and emerging technology developers.
According to the source report, Medtronic accounts for approximately 24% market share, followed by Abbott at approximately 20%.
Leading manufacturers are emphasizing advanced drug-eluting technologies, bioengineered materials, and improved stent delivery systems.
Strategic partnerships, clinical research programs, product approvals, and international distribution networks are important competitive strategies.
Future Outlook
The Stents Market is expected to maintain steady growth through 2034, supported by continuous technological advancements and increasing demand for minimally invasive treatments.
Future innovations are likely to focus on bioresorbable scaffolds, polymer-free drug-eluting stents, ultra-thin structures, and advanced surface coatings.
Expanding cardiovascular treatment infrastructure in emerging economies will create additional opportunities for manufacturers.
Research into biologically compatible materials and improved vessel healing technologies is also expected to influence future product development.
Get a free sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/stents-market-100672
Conclusion
The global Stents Market is positioned for sustained expansion, with its value projected to reach USD 21.54 billion by 2034. Rising cardiovascular disease prevalence, technological innovation, and increasing adoption of minimally invasive procedures remain major growth factors.
North America continues to lead the industry, while Asia Pacific offers opportunities for future expansion. As manufacturers prioritize patient safety, device performance, and advanced materials, next-generation stent technologies are expected to play an increasingly important role in interventional healthcare.
Top 5 Trending FAQs About the Stents Market
1. How big is the global Stents Market?
According to Fortune Business Insights, the global Stents Market was valued at USD 15.44 billion in 2025 and is projected to reach USD 21.54 billion by 2034.
2. At what CAGR is the Stents Market expected to grow?
The market is expected to exhibit a CAGR of 3.77% during the forecast period of 2026–2034.
3. Which segment dominates the Stents Market?
The coronary stents segment dominated the market with approximately 45% share in 2025, driven by the increasing prevalence of coronary artery disease and growing demand for minimally invasive cardiac procedures.
4. Who are the major players in the Stents Market?
Major players include Medtronic, Abbott, Boston Scientific Corporation, BD, Cardinal Health, and Terumo Corporation.
5. What are the key trends shaping the Stents Market?
Major trends include increasing adoption of advanced drug-eluting stents, development of bioresorbable vascular scaffolds, growing interest in bioengineered stents, and greater use of imaging-guided implantation techniques.
What’s Driving Japan’s Market? Discover the Latest Stents Market Insights